An elevated intraocular pressure (IOP) is one of the risk factors for the development of glaucoma. Recent prospective epidermal studies in the United States indicate that if IOP is lowered below 12 mmHg, 1) or by more than 30% from the baseline IOP in patients with normal-tension glaucoma, 2) the progress of the visual field defect can be delayed. Prostaglandin (PG) derivatives exert ocular-hypotensive effects through stimulation of prostanoid receptors (FP, DP, IP etc.) and possibly by activation of signal-transduction systems such as intracellular Ca 2ϩ and cyclic AMP. 3-6) One of the most potent PGF 2a derivatives at reducing IOP is latanoprost, a selective prostanoid FP-receptor agonist, and this drug has been successfully developed as an anti-glaucoma agent. 7) Recently, another selective prostanoid FP-receptor agonist, travoprost, was launched in the United States and other countries. 8) Because of their potent, long-lasting ocular-hypotensive effects, prostanoid FP-receptor agonists are widely used for the treatment of glaucoma.
solution was 133 NaCl, 16.1 NaHCO 3 , 4.7 KCl, 2.4 CaCl 2 , 1.4 NaH 2 PO 4 , 1.0 MgCl 2 and 7.8 glucose. A resting tension of 100 mg was applied. After baseline tension had been established (following equilibration for at least 60 min), the maximum constriction of the iris sphincter muscle was measured after dosing with PGF 2a at 1 mM. Then, the constrictions were measured after cumulative dosing with the various PGF 2a derivatives. Force transducers (FD pickup, TB-612T, Nihon Kohden, Tokyo, Japan) for the measurement of isometric constriction were connected to a polygraph for registration of the response. The PGF 2a -derivative-induced constriction was expressed as a percentage of the 1 mM PGF 2ainduced constriction, which was taken as 100% constriction. Concentration-response data were subjected to regression analysis to determine the concentration which shows 50% constriction (EC 50 ).
Melanin Content of Cultured B16-F10 Melanoma Cells
Melanin content was measured according to the method of Siegrist and Eberle. 26) Murine B16-F10 melanoma cells (Teikyo University, Kanagawa, Japan) were maintained in minimum essential medium supplemented with 10% heat-inactivated fetal bovine serum, 1% non-essential amino acid solution, penicillin (50 U/ml, Life Technologies) and streptomycin (50 mg/ml, Life Technologies) at 37°C in a humid atmosphere of 5% CO 2 /95% air. The cells were seeded at a density of 2.0ϫ10 3 cells/ml in 24-well culture plates containing the culture medium described above. After preincubation of the cells under the above conditions for 24 h, a given PGF 2a derivative was added to the medium at various desired concentrations. Forty-eight hours later, the medium was changed for an identical medium containing the same concentration of the same PGF 2a derivative. Then, all culture plates were incubated for 48 h (total incubation time was 96 h). After the incubation, all culture plates were used for assays of melanin content. Duplicate 200 ml samples of culture medium were taken and placed into a 96-well immunoplate. After removal of the culture medium, cells were washed twice with PBS(Ϫ), then sonicated in 0.1 N NaOH containing 10% Triton X-100. Duplicate 200 ml samples of the cell lysate were placed into a 96-well immunoplate. The absorbance of the culture medium and the cell lysate were measured at 415 nm at the same time as those of a series of doubling dilutions of a synthetic melanin standard. The melanin contents of the culture medium and cell lysate were calculated with the aid of an analytical curve for melanin standard solution. The amount of proteins in the cell lysate was measured, employing BCA protein-assay reagent ® . Changes in melanin content were calculated using the following equation and expressed as a percentage of the amount of melanin in the absence of PGF 2a derivatives.
Changes in melanin content (%)ϭ((AsϩBs)/Ps/(AcϩBc)/Pc)ϫ100
Ac: melanin content of the culture medium in the absence of a PGF 2a derivative Bc: melanin content of the cell lysate in the absence of a PGF 2a derivative Pc: amount of protein in a cell lysate in the absence a PGF 2a derivative As: melanin content of the culture medium in the presence of a PGF 2a derivative Bs: melanin content of the cell lysate in the presence of a PGF 2a derivative Ps: amount of protein in a cell lysate in the presence of a PGF 2a derivative Pupillary Diameter in Cats Topical application of prostanoid FP-receptor agonists has been reported to produce a dose-related miotic effect in the cat. 27) The miotic effects of the PGF 2a derivatives were examined in male European cats (Charles River Japan; weight, 3.0 to 3.5 kg) anaesthetized by intramuscular injection of ketamine hydrochloride (Sankyo, Tokyo, Japan) at 7.0-9.0 mg/kg. PGF 2a derivatives were administered in 50 ml aliquots to one eye in each animal, with vehicle (also 50 ml) being simultaneously administered to the contralateral eye. Then, the two eyes in each cat were photographed 0, 1, 3, 5, 7, 9 and 24 h later. Pupil diameter (PD) was measured horizontally across the width of the pupil on the photograph using an electrical pupillary ruler (Mitutoyo Co., Kanagawa, Japan). Changes in PD in the PGF 2a derivative-treated eyes were expressed as a percentage of the PD of the contralateral vehicle-treated eye in order to normalize the effects of systemic anaesthesia on PD.
Intraocular Pressure in Conscious Monkeys
The IOPreducing effects of PGF 2a derivatives were examined in 6 ocular-normotensive cynomolgus monkeys (Keary, Osaka, Japan) weighing from 2.0 to 6.0 kg (3 to 8 years old, male). The animals had been trained to accept restraint in monkey chairs, instillation of eye drops and IOP measurement using a pneumatonometer (model 30-Classic; SOLAN, FL, U.S.A.) before this experiment. A given PGF 2a derivative was topically applied in one 20 ml aliquot to one eye, with vehicle (20 ml) being administered to the contralateral eye. IOP was measured using a pneumatonometer under corneal anaesthesia with 0.4% oxybuprocaine hydrochloride (Santen, Osaka, Japan). IOP measurements were performed 0, 2, 4, 6 and 8 h after topical application of PGF 2a derivatives and vehicle.
All cats and monkeys used were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Statistical Analysis All data are presented as the meanϮstandard error. Statistical significance was assessed using a Student's t-test or an analysis of variance (ANOVA) followed by Dunnett's multiple-comparison test. pϽ0.05 was considered statistically significant in each form of analysis.
RESULTS

Constriction in Isolated Cat Iris Sphincters
The PGF 2a -derivatives-induced constrictions observed in isolated cat iris sphincters are shown in Table 2 . A carboxylic acid of latanoprost induced constriction with an EC 50 value of 13.6 nM. Cloprostenol and several other PGF 2a derivatives were more powerful with EC 50 values of 0. Melanin Contents of Cultured B16 Melanoma Cells The effects of PGF 2a derivatives on the melanin content of cultured B16-F10 melanoma cells are shown in Table 3 . A carboxylic acid of latanoprost (1 to 100 mM) dose-dependently increased the melanin content, the effect being significant at 10 and 100 mM. Similary, AFP-113 (1 to 100 mM) and AFP-159 (100 mM) significantly increased the melanin con-tent. On the other hand, AFP-172, AFP-157 and AFP-162 each of which possesses two fluorine atoms at the 15-position, did not increase the melanin content, even at 100 mM.
Miotic Effects in Anaesthetized Cats The miotic effects of PGF 2a derivatives in anaesthetized cats are shown in Fig. 1 . AFPs-172, 157 and 162 were chosen as the basic structures for this experiment on the basis of the in vitro experiments. Topical application of latanoprost at 0.001 to 0.01% induced a miosis, with pupillary diameter decreasing to approximately 20% of control. AFP-170 (AFP-157 methyl ester) and AFP-173 (AFP-162 methyl ester) each induced a miosis of about the same magnitude as latanoprost. On the other hand, AFP-169, 175 and 168 (methyl ester, ethyl ester and isopropyl ester of AFP-172, respectively) had more potent miotic effects than latanoprost. The rank order of potencies for the various ester forms of AFP-172 was AFP-169ϭAFP-168ϾAFP-175.
Effects on Intraocular Pressure in Conscious Monkeys
The effects of AFP-168 and latanoprost on IOP in conscious ocular-normotensive monkeys are shown in Fig. 2 . We chose AFP-168 (AFP-172 isopropyl ester) for this experiment since AFP-168 had the most potent miotic effect in cats. Latanoprost (0.005%) lowered IOP significantly at 4 and 6 h Constrictions induced by drugs applied cumulatively were normalized with respect to the maximal response induced by 1 mM prostaglandin F 2a in each experiment. Concentration-response data were subjected to regression analysis to determine the concentration at which 50% constriction occurred (EC 50 ). Data represent the meanϮS.E. In each experiment, a carboxylic acid of latanoprost was used as a positive control. after its topical application. AFP-168 (0.0005%) lowered IOP significantly at 4, 6 and 8 h after its topical application. No evidence of eye irritability was observed after topical application of either AFP-168 or latanoprost at the concentrations used in the present experiment.
DISCUSSION
We synthesized new PGF 2a derivatives and investigated their prostanoid FP-receptor-mediated functional activities both in vitro and in vivo. In our in vitro experiments, 15monofluoro derivatives caused constriction of the cat isolated iris sphincter, suggesting that exchanging the 15-hydroxy group for fluorine preserves prostanoid FP-agonistic activities, in keeping with the findings on 15-monofluoro PGF 2a published by Nigamatov et al. 28) Furthermore, we found that 15,15-difluoro derivatives (namely, AFPs-162, 164, 157 and 172) also retained the iris constrictor activity. When the iris constrictor activities of a mono-fluoro derivative (AFP-159) and a difluoro derivative (AFP-162) were compared, AFP-162 was found to be the more potent of the two ( Table 2 ). Interestingly, 15,15-difluoro derivatives, such as AFP-172 and AFP-157, did not increase the melanin content of cultured B16-F10 melanoma cells, although a carboxylic acid of latanoprost did, as reported by other investigators. 29) Taken together, these observations suggest that fluorine atom(s) in the 15-position of the structure contributes, at least in part, to increase the FP receptor-related activities and to reduce the side effects such as melanogenesis.
For our in vivo experiments we used esterified 15,15-difluoro derivatives, which induced stronger constrictions in the cat iris sphincter than a carboxylic acid of latanoprost, because the ester forms of PGF 2a derivatives are well known to improve the corneal permeability of the free-acid forms of the derivatives. 30) When topically applied, the methyl ester forms of AFPs-162, 157 and 172 each induced a significant miosis in cats in a dose-dependent manner. Their effects at inducing miosis seemed to be consistent with their in vitro activities. Although the in vitro activities of AFPs-162 and 157 were 6 to 7 times greater than that of a carboxylic acid of latanoprost (Table 2) , this was not the case in the in vivo experiment ( Fig. 1) . However, the methyl, ethyl and isopropyl ester forms of AFP-172 (each at 0.0001%) reduced pupillary diameter in the cat eye to the same extent as 0.001% latanoprost. A similar relationship was observed in the IOP experiment, in which the ocular-hypotensive effect of 0.0005% AFP-168 (a isopropyl ester form of AFP-172) was equivalent to that of 0.005% latanoprost in conscious ocularnormotensive monkeys (Fig. 2) . These results indicate that 15,15-difluoro PGF 2a derivatives can exhibit potent prostanoid FP-receptor agonistic activities in the eye. PGF 2a -derivative ophthalmic solutions, including latanoprost solution, have been reported to cause an iris colour change and dark skin around the eye as side effects. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] In cultured melanoma cells, a carboxylic acid of latanoprost has been reported to increase melanogenesis 31) and the results obtained in the present study confirm this report. However, the stimulatory effects on melanin content in cultured B16-F10 melanoma cells in our experiment did not correlate with the prostanoid FP-receptor agonistic activities of the 15,15-difluoro derivatives. The mechanism underlying this phenomenon remains to be revealed, but the lack of stimulatory effects of 15,15-difluoro derivatives on melanin content in these cultured cells may mean that topical application of the ester types of the derivatives may cause pigmentation less frequently or less severely than latanoprost. Future longterm topical-application studies with 15,15-difluoro derivatives in monkeys and/or in the clinic will be required to test this idea.
In conclusion, our in vitro and in vivo findings indicate that the new 15-monofluoro and 15,15-difluoro PGF 2a derivatives tested here have potent prostanoid FP-agonistic activities with minimal side effects. These derivatives are worthy of further investigation as potential anti-glaucoma agents.
